Although the number of samples tested in this study is too small to draw definitive conclusions, deregulation of TGFβ signalling through hypermethylation of these genes may affect tumour progression as well as patients’ prognosis, resulting in more aggressive local and distant metastatic spread, including the bone. This evidence concerns the gene TGFB1 and neoplasm.